Impact of Sex on Morbidity and Mortality Rates After Lower Extremity Interventions for Peripheral Arterial Disease
Abstract
No abstract availableKeywords
Funding Information
- Blue Cross Blue Shield of Michigan
- National Institutes of Health
- Blue Cross Blue Shield of Michigan
- NIH, the Agency for Healthcare Research and Quality, and Blue Cross Blue Shield of Michigan
- NIH, Blue Cross Blue Shield of Michigan, and Medtronic Cardiovascular
This publication has 21 references indexed in Scilit:
- Executive Summary: Heart Disease and Stroke Statistics—2013 UpdateCirculation, 2013
- How A Regional Collaborative Of Hospitals And Physicians In Michigan Cut Costs And Improved The Quality Of CareHealth Affairs, 2011
- The association of sex with outcomes among patients undergoing primary percutaneous coronary intervention for ST elevation myocardial infarction in the contemporary era: Insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2)American Heart Journal, 2011
- Defining the Optimal Degree of Heparin Anticoagulation for Peripheral Vascular InterventionsCirculation: Cardiovascular Interventions, 2010
- Lessons learned from the analysis of gender effect on risk factors and procedural outcomes of lower extremity arterial diseaseJournal of Vascular Surgery, 2010
- Sex Differences in Mortality Following Acute Coronary SyndromesJAMA, 2009
- The joint contribution of sex, age and type of myocardial infarction on hospital mortality following acute myocardial infarctionHeart, 2009
- Ethnic-Specific Prevalence of Peripheral Arterial Disease in the United StatesAmerican Journal of Preventive Medicine, 2007
- Gender Differences in Short-Term Cardiovascular Outcomes After Percutaneous Coronary InterventionsThe American Journal of Cardiology, 2006
- Development of a multicenter peripheral arterial interventional database: The PVD-QI2American Heart Journal, 2005